These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 629272)

  • 1. Resistance to endogenous norepinephrine in Bartter's syndrome: reversion during indomethacin administration.
    Silverberg AB; Mennes PA; Cryer PE
    Am J Med; 1978 Feb; 64(2):231-5. PubMed ID: 629272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of prostaglandins in the pathogenesis of Bartter's syndrome.
    Fichman MP; Telfer N; Zia P; Speckart P; Golub M; Rude R
    Am J Med; 1976 May; 60(6):785-97. PubMed ID: 798488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the kallikrein-kinin system and vascular reactivity in Bartter's syndrome.
    Rodriguez-Portales JA; Lopez-Moreno JM; Mahana D
    Hypertension; 1985; 7(6 Pt 1):1017-22. PubMed ID: 2416684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A defect in platelet aggregation in Bartter's syndrome.
    Stoff JS; Stemerman M; Steer M; Salzman E; Brown RS
    Am J Med; 1980 Feb; 68(2):171-80. PubMed ID: 6243857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of indomethacin on the vascular abnormalities of Bartter's syndrome.
    Richards CJ; Mark AL; Van Orden DE; Kaloyanides GJ
    Circulation; 1978 Sep; 58(3 Pt 1):544-9. PubMed ID: 679446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism?
    Donker AJ; de Jong PE; van Eps LW; Brentjens JR; Bakker K; Doorenbos H
    Nephron; 1977; 19(4):200-13. PubMed ID: 917167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive peptides in Bartter's syndrome.
    Stahl MM; Vaara I; Hedner P; Ekman R
    Eur J Clin Invest; 1993 Feb; 23(2):80-3. PubMed ID: 8462624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of plasma atrial natriuretic peptide in Bartter's syndrome fall to normal with indomethacin: implications for atrial natriuretic peptide regulation in man.
    Gordon RD; Tunny TJ; Klemm SA; Hamlet SM
    J Hypertens Suppl; 1986 Dec; 4(6):S555-8. PubMed ID: 2956391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma and urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome (author's transl)].
    Hornych A
    Nephrologie; 1980; 1(3):113-6. PubMed ID: 6945487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of altered vascular responsiveness in Bartter's syndrome by indomethacin treatment.
    Shimoyama R
    J Clin Endocrinol Metab; 1980 Oct; 51(4):908-11. PubMed ID: 6999001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indomethacin and atrial natriuretic peptide in Bartter's syndrome.
    Gordon RD; Tunny TJ; Klemm SA
    N Engl J Med; 1986 Aug; 315(7):459. PubMed ID: 2942775
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythrocyte sodium transport in Bartter's syndrome.
    Uchiyama M; Shah V; Daman Willems C; Dillon MJ
    Acta Paediatr Scand; 1988 Nov; 77(6):873-8. PubMed ID: 2849851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man.
    Klemm SA; Tunny TJ; Gordon RD
    J Hypertens Suppl; 1987 Dec; 5(5):S75-8. PubMed ID: 2965235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of hypokalemia corrects the abnormalities in erythrocyte sodium transport in Bartter's syndrome.
    Korff JM; Siebens AW; Gill JR
    J Clin Invest; 1984 Nov; 74(5):1724-9. PubMed ID: 6501567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bartter's syndrome presenting with features resembling renal tubular acidosis. Improvement of renal tubular defects by indomethacin.
    Rodriguez-Soriano J; Vallo A; Oliveros R
    Helv Paediatr Acta; 1978 Jun; 33(2):141-51. PubMed ID: 659258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent roles of prostaglandins and the renin-angiotensin system in abnormal vascular reactivity in Bartter's syndrome.
    Fujita T; Ando K; Sato Y; Yamashita K; Nomura M; Fukui T
    Am J Med; 1982 Jul; 73(1):71-6. PubMed ID: 7046439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bartter's syndrome with normal chloride reabsorption during indomethacin treatment.
    Hornych A; Huet de Barochez Y; Bariéty J; Branca GF; Vigeral P; Girard JF; Kazatchkine M; De Gennes JL; Truffert J; Bocquet L
    Nephron; 1987; 46(2):137-43. PubMed ID: 3600922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin suppresses plasma aldosterone concentration in a case of Bartter's syndrome.
    Shigeta H; Tasaki N; Kitazumi S; Kitagawa Y; Nakano K; Kanatsuna T; Kondo M
    Endocrinol Jpn; 1987 Apr; 34(2):309-12. PubMed ID: 2887425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of indomethacin in a patient with Bartter's syndrome: evidence against a primary role of prostaglandin in this disorder.
    Etzioni A; Chaimovitz C; Levi Y; Benderli A; Better OS
    Pediatr Res; 1980 Dec; 14(12):1395-7. PubMed ID: 7010289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A circulating inhibitor of platelet aggregation in Bartter's syndrome.
    O'Reagan SO; Rivard GE; Mongeau JG; Robitaille PO
    Pediatrics; 1979 Dec; 64(6):939-41. PubMed ID: 117424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.